Concepedia

Jens Ackerstaff

JA

Statistics

Publications

2

Citations

227

H-Index

2

Active since

2017

Affiliations

Bayer (Germany)(Current)

Jens Ackerstaff is an author at Bayer (Germany) specializing in pharmacology, drug discovery, and once-daily dosing regimens.

Publications per year

2017–2023

2

Publications

2

Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure

Markus Follmann, Jens Ackerstaff, Gorden Redlich et al. · Journal of Medicinal Chemistry · 2017 · 197 citations · Full text

, , +17

Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders

Susanne Roehrig, Jens Ackerstaff, Eloísa Jiménez Núñez et al. · Journal of Medicinal Chemistry · 2023 · 30 citations · Full text

, , +16

1–2 of 2